|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1215 K STREET, #700 |
Address2 |
|
City | SACRAMENTO |
State | CA |
Zip Code | 95814 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 7747-12
|
||||||||
|
6. House ID# 334020000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Anne O'Rourke |
Date | 10/19/2022 2:12:16 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Q3 Lobbying Report (July 1- September 30)
HCR
Provider Relief Fund Deadline Extension Act (S. 2493/H.R. 4735)
Infrastructure Investment and Jobs Act
Build Back Better Act (H.R. 5376)
Dr. Lorna Breen Health Care Provider Protection Act (HR 1667)
Provider Relief Fund Improvement Act (H.R. 5963 / S. 3611)
Public Service Loan Forgiveness program/physician federal loan forgiveness
Healthcare Workforce Resilience Act of 2021
Black Maternal Health Momnibus Act of 2021 (S. 346/H.R. 959)
Regulatory relief in light of coronavirus
Transparency (surprise medical bills; public posting of hospital charges)
340B Drug Pricing Program, including S. 773/H.R. 3203
Resident Physician Shortage Act (S. 834/H.R. 2256)
No Surprises Act regulations
Public Health Emergency designation
Blood shortages
PREVENT Pandemics Act (S. 3799)
CMS Region IX re: Guidance on California State Bill 311 The Compassionate Access to Medical Cannabis Act
Meeting with OMB re: Physician Loan Forgiveness
CMS Regional Office re: Admission, Discharge, and Transfer Patient Event Notification Conditions of Participation (42 CFR 482.24(d), 482.61(f), and 485.638(d))
Food and Drug Amendments of 2022 (H.R. 7667)
Improving Seniors Timely Access to Care Act (H.R. 1587/S. 3018)
Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 7961)
Bipartisan Safer Communities Act (S. 2938)
Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666)
Saving Access to Laboratory Services Act (SALSA Act) (H.R. 8188/S.4449)
Assistance for Rural Community Hospitals (ARCH) Act (H.R. 8747)
Meetings with FEMA re: COVID-19 related reimbursement
MMM
Accelerated and Advance Payment Program repayment flexibility (H.R. 1349, The COVID-19 Hospital and Health Provider Loan Conversion Act of 2021)
Graduate Medical Education (GME) funding (Resident Physician Shortage Reduction Act of 2021 (S. 834/H.R. 2256)
Telehealth flexibilities and payment (TREAT Act - S. 168/H.R. 708; Telehealth Modernization Act -S. 368/H.R. 1332)
Hospital Inpatient Services Modernization Act (H.R. 7053)
Annual Prospective Payment System Rules
Organ acquisition payment policies
Clinical lab fee schedule
BUD
FY2022 Appropriations bills
Consolidated Appropriations Act of 2022 (HR 2471) - omnibus
Further Additional Extending Government Funding Act, HR 6617
Nursing and allied health workforce funding
FY 2023 budget request
Submitted Comments
Methodology for Preventing Duplication of FEMA Benefits
SUBJECT: Forthcoming Guidance on Discharge Planning Requirements; August 4, 2022
RE: Public Service Loan Forgiveness Regulations Docket ID ED-2021-OPE-0077: Student Assistance General Provisions, Federal Perkins Loan Program, Federal Family Ed Loan Program, and William D. Ford Federal Direct Loan Program
SUBJECT: CMS-4203-NC, Medicare Program; Request for Information on Medicare; Vol. 87, No. 146, August 1, 2022
SUBJECT: CMS-3419-P, Medicare and Medicaid Programs; Conditions of Participation (CoPs) for rural emergency hospitals and critical access hospital CoPs Updates (Vol 87, No 128), July 6, 2022
SUBJECT: CMS-1772-P, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Acquisition; Rural Emergency Hospitals: Payment Policies, Conditions of Participation, Provider Enrollment, Physician Self-Referral; New Service Category for Hospital Outpatient Department Prior Authorization Process; Overall Hospital Quality Star Rating, (Vol 87, No 142), July 26, 2022
SUBJECT: CMS-1770-P, Medicare and Medicaid Programs; CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Medicare and Medicaid Provider Enrollment Policies, Including for Skilled Nursing Facilities; Conditions of Payment for Suppliers of Durable Medicaid Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); and Implementing Requirements for Manufacturers of Certain Single-Dose Container or Single-Use Package Drugs To Provide Refunds With Respect to Discarded Amounts (Vol 87, No 145), July 29, 2022
SUBJECT: CMS1766P Medicare Program; Calendar Year 2023 Home Health Prospective Payment System Rate Update; Home Health Quality Reporting Program Requirements; Home Health Value Based Purchasing Expanded Model Requirements; and Home Infusion Therapy Services Requirement; Federal Register (Vol. 87, No. 120) June 23, 2022
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anne |
O'Rourke |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |